Table 1.
Protocol parameters for the use of Septex with Prismaflex §.
| Treatment Parameters | RCA-CVVHD | Heparin-CVVHD | CVVHD without Anticoagulation | RCA-CVVHD: Treatment for 80 Kg Patient |
|---|---|---|---|---|
| Blood flow rate (mL/min) | 120–160 | 160–200 | 160–200 | 140 |
| Dialysis dose (mL/kg/h) | 30 A | 30 B,C | 30 B,C | 30 A (2400 mL/h) |
| 4% citrate flow (mL/h) | 160-210 | - | - | 185 |
| Calcium compensation (%) | 100 * | - | - | 100 * |
| Citrate dose (mmol/L) | 3.0 # | - | - | 3.0 # |
Systemic, post-filter ionized calcium (iCa) and total blood calcium concentration (CaTOT) are checked according to the RCA-CVVHD protocol. RCA: regional citrate anticoagulation *: initial value, then according to the systemic iCa. #: initial value, then according to the post-filter iCa. A: dialysate calcium free (Prism0Cal B22§), B: emodiafiltration fluid (Prismasol 2§), C: emodiafiltration fluid (Phoxilium§) §:(Baxter, IL, USA).